We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
LHC Group (LHCG) Q3 Earnings and Revenues Beat Estimates
Read MoreHide Full Article
LHC Group, Inc.’s third-quarter 2020 adjusted earnings per share (EPS) of $1.63 surpassed the Zacks Consensus Estimate of $1.32 by 23.5%. Moreover, the bottom line improved 29.4% year over year.
The company reported net service revenues of $530.7 million in the quarter, which beat the Zacks Consensus Estimate by 1.5%. Further, the top line inched up 0.4% on a year-over-year basis.
Q3 Highlights
In the quarter under review, total organic growth in home health admissions rose 4.7% year over year, while organic growth in hospice admissions climbed 12.8%.
However, home health service revenues were $373.5 million, down 0.6% year over year. Meanwhile, hospice services revenues amounted to $59.8 million, up 3.6%.
Business Update
On Aug 1, 2020, LHC Group finalized a joint venture with Orlando Health to boost home health and home and community based services (HCBS) in the state of Florida. The company anticipates this joint venture (JV) to account for almost $3.5 million in incremental annualized revenues.
On Oct 1, 2020, the company finalized a JV with University Health Care System to bolster home health and hospice services in Georgia and South Carolina. The company expects this joint venture to account for almost $8.3 million in incremental annualized revenues. In the same month, the company finalized a JV with Northeast Georgia Health System in order to share ownership of SunCrest Home Health in Gainesville, GA.
On Nov 1, 2020, LHC Group finalized an expansion of JV with CHRISTUS Health via an agreement of adding a hospice provider in San Marcos, TX. The company anticipates this joint venture to account for almost $2.1 million in incremental annualized revenues.
Margin Analysis
Gross profit in the quarter totaled $225.4 million, up 16.4%. Gross margin in the reported quarter was 42.5%, which expanded 580 basis points (bps) on a year-over-year basis.
Operating profit was $19.5 million, plunged 58.2% from the prior-year quarter. Operating margin was 3.7%, down 510 bps.
2020 Guidance Raised
LHC Group is raising its full-year 2020 guidance (that was withdrawn on May 7,2020) and then reinstated on Aug 5, 2020.
For full-year 2020, the company projects net service revenues between $2.06 and $2.07 billion (up from the previously guided range of $2 billion to $2.05 billion). The Zacks Consensus Estimate for the same is pegged at $2.06 billion.
Adjusted EPS is expected in the range of $4.90-$5.00 (up from the prior issued ranged of $4.60-$4.80). The consensus mark for the same is pegged at $4.76 per share.
Wrapping Up
LHC Group exited the third quarter on a strong note. The company continues to gain from home health and hospice admissions with both witnessing organic growth on a year-over-year basis. Increase in the bottom line buoys optimism. LHC Group is also anticipated to benefit from JVs. Expansion is gross margin is encouraging.
However, the company witnessed decline in home health service revenues in the quarter under review. Also, contraction in operating margin raises concern. Further, a highly competitive home healthcare market remains a woe.
Align Technology reported third-quarter 2020 adjusted EPS of $2.25, which surpassed the Zacks Consensus Estimate by 281.4%. Revenues of $734.1 million outpaced the consensus mark by 38%.
Thermo Fisher reported third-quarter 2020 adjusted EPS of $5.63, beating the Zacks Consensus Estimate by 28.8%. Revenues of $8.52 billion surpassed the consensus mark by 10%.
AngioDynamics reported first-quarter fiscal 2021 adjusted earnings per share (EPS) of 2 cents against the Zacks Consensus Estimate of a loss per share of 6 cents. Revenues of $70.2 million beat the consensus mark by 6.9%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
LHC Group (LHCG) Q3 Earnings and Revenues Beat Estimates
LHC Group, Inc.’s third-quarter 2020 adjusted earnings per share (EPS) of $1.63 surpassed the Zacks Consensus Estimate of $1.32 by 23.5%. Moreover, the bottom line improved 29.4% year over year.
The company reported net service revenues of $530.7 million in the quarter, which beat the Zacks Consensus Estimate by 1.5%. Further, the top line inched up 0.4% on a year-over-year basis.
Q3 Highlights
In the quarter under review, total organic growth in home health admissions rose 4.7% year over year, while organic growth in hospice admissions climbed 12.8%.
However, home health service revenues were $373.5 million, down 0.6% year over year. Meanwhile, hospice services revenues amounted to $59.8 million, up 3.6%.
Business Update
On Aug 1, 2020, LHC Group finalized a joint venture with Orlando Health to boost home health and home and community based services (HCBS) in the state of Florida. The company anticipates this joint venture (JV) to account for almost $3.5 million in incremental annualized revenues.
LHC Group, Inc. Price, Consensus and EPS Surprise
LHC Group, Inc. price-consensus-eps-surprise-chart | LHC Group, Inc. Quote
On Oct 1, 2020, the company finalized a JV with University Health Care System to bolster home health and hospice services in Georgia and South Carolina. The company expects this joint venture to account for almost $8.3 million in incremental annualized revenues. In the same month, the company finalized a JV with Northeast Georgia Health System in order to share ownership of SunCrest Home Health in Gainesville, GA.
On Nov 1, 2020, LHC Group finalized an expansion of JV with CHRISTUS Health via an agreement of adding a hospice provider in San Marcos, TX. The company anticipates this joint venture to account for almost $2.1 million in incremental annualized revenues.
Margin Analysis
Gross profit in the quarter totaled $225.4 million, up 16.4%. Gross margin in the reported quarter was 42.5%, which expanded 580 basis points (bps) on a year-over-year basis.
Operating profit was $19.5 million, plunged 58.2% from the prior-year quarter. Operating margin was 3.7%, down 510 bps.
2020 Guidance Raised
LHC Group is raising its full-year 2020 guidance (that was withdrawn on May 7,2020) and then reinstated on Aug 5, 2020.
For full-year 2020, the company projects net service revenues between $2.06 and $2.07 billion (up from the previously guided range of $2 billion to $2.05 billion). The Zacks Consensus Estimate for the same is pegged at $2.06 billion.
Adjusted EPS is expected in the range of $4.90-$5.00 (up from the prior issued ranged of $4.60-$4.80). The consensus mark for the same is pegged at $4.76 per share.
Wrapping Up
LHC Group exited the third quarter on a strong note. The company continues to gain from home health and hospice admissions with both witnessing organic growth on a year-over-year basis. Increase in the bottom line buoys optimism. LHC Group is also anticipated to benefit from JVs. Expansion is gross margin is encouraging.
However, the company witnessed decline in home health service revenues in the quarter under review. Also, contraction in operating margin raises concern. Further, a highly competitive home healthcare market remains a woe.
Zacks Rank
LHC Group carries a Zacks Rank #3 (Hold).
Earnings of Other MedTech Majors at a Glance
Some better-ranked stocks in the broader medical space that have already announced their quarterly results are Thermo Fisher Scientific Inc. (TMO - Free Report) , Align Technology, Inc. (ALGN - Free Report) and AngioDynamics, Inc. (ANGO - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Align Technology reported third-quarter 2020 adjusted EPS of $2.25, which surpassed the Zacks Consensus Estimate by 281.4%. Revenues of $734.1 million outpaced the consensus mark by 38%.
Thermo Fisher reported third-quarter 2020 adjusted EPS of $5.63, beating the Zacks Consensus Estimate by 28.8%. Revenues of $8.52 billion surpassed the consensus mark by 10%.
AngioDynamics reported first-quarter fiscal 2021 adjusted earnings per share (EPS) of 2 cents against the Zacks Consensus Estimate of a loss per share of 6 cents. Revenues of $70.2 million beat the consensus mark by 6.9%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>